In a retrospective cohort of 5799 families (men/women) from the HBOC group, an increased risk of PC was observed in breast and ovarian cancer patients both carrying BRCA1 and BRCA2 gene mutations. This evidence concerns the gene BRCA1 and ovarian cancer.